General Information of Disease (ID: DISH3GHR)

Disease Name Lung carcinoid tumor
Synonyms
lung carcinoid; carcinoid tumour of the lung; lung carcinoid tumour (disease); carcinoid tumour of lung; carcinoid tumour (disease) of lung; lung carcinoid tumor; pulmonary carcinoid tumor; carcinoid tumor (disease) of lung; pulmonary carcinoid tumour; carcinoid tumor of lung; lung carcinoid tumor (disease); carcinoid tumor of the lung
Definition
A neuroendocrine neoplasm that arises from the lung. It is characterized by the presence of uniform polygonal cells with small or moderate amount of cytoplasm and inconspicuous nucleoli. The cells are usually arranged in organoid and trabecular patterns. It is classified as typical or atypical carcinoid tumor based on the number of mitotic figures and the absence or presence of necrosis. Atypical carcinoid tumors have a worse prognosis.
Disease Hierarchy
DISMNRDC: Carcinoid tumor
DISLTBIC: Lung neuroendocrine neoplasm
DISH3GHR: Lung carcinoid tumor
Disease Identifiers
MONDO ID
MONDO_0006041
UMLS CUI
C0280089
MedGen ID
79070
HPO ID
HP:0030445
SNOMED CT ID
254627002

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Romidepsin DMT5GNL Approved Small molecular drug [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
PYGM TTZHY6R Limited Genetic Variation [2]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
MEN1 OTN6U6V0 Strong Genetic Variation [2]
------------------------------------------------------------------------------------

References

1 Romidepsin FDA Label
2 Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis.Cancer Res. 1997 May 15;57(10):1855-8.